Semanteon Capital Management, LP / CRNX
Semanteon Capital Management, LP’s Crinetics Pharmaceuticals In Position
Does Semanteon Capital Management, LP own Crinetics Pharmaceuticals In (CRNX)? Yes — 5.6K shares worth $202,012 (+2.71% of its 13F portfolio) as of Q1 2026.
Position Value
$202,012
Q1 2026
Shares
5.6K
% of Portfolio
+2.71%
Quarters Held
1
currently held
Position History CRNX
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 5.6K | $202,012 | +2.71% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Semanteon Capital Management, LP’s full portfolio or all institutional holders of CRNX.